Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics drug gets OK for additional cancer therapies in Europe
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Submitted by
admin
on July 6, 2016 - 11:08am
Source:
Bizjournals.com
News Tags:
Seattle Genetics
Europe
Adcetris
Hodgkin's lymphoma
Headline:
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Do Not Allow Advertisers to Use My Personal information
